First AD

Second AD

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

The Evolving Treatment Paradigm for Stage I-IIIA NSCLC

Peer Exchange

Joshua Sabari, MD, describes which stage groups of patients with NSCLC should receive neoadjuvant therapies, and which therapies are typically used.

Selecting Appropriate Patients with NSCLC for Neoadjuvant Therapy

Recommendations for Molecular Testing in Non-Small Cell Lung Cancer (NSCLC)

Molecular Testing in Early NSCLC to Guide Treatment Decision Making

Is There a Role for Liquid Biopsies in Early NSCLC?

Updates in the Treatment of Stage I-IIIA NSCLC

The Role of Neoadjuvant Therapy in Patients with Resectable NSCLC

The Role of Adjuvant Therapy in Patients with NSCLC

Updates on Adjuvant Osimertinib for NSCLC Treatment from the ADUARA Trial

Adjuvant Therapy in EGFR-Mutated NSCLC

NSCLC Molecular Testing Recommendations for Community Hospitals

Exciting NSCLC Data Updates from ESMO 2022